Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

INFQInfleqtion, Inc.

NYSE · CIK 0002007825
Filer categoryNon-accelerated filer<br>Emerging growth company
Entity typeoperating
SIC7374 Services-Computer Processing & Data Preparation
FY end1231
XBRL facts191

Identity from submissions API

NameInfleqtion, Inc.
CIK0002007825
TickersINFQ, INFQ-WT
ExchangesNYSE, NYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Emerging growth company
SIC7374 Services-Computer Processing & Data Preparation
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(303) 440-1284
Website—
Investor website—
Owner org06 Technology
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Churchill Capital Corp X/Cayman (2024-03-08T05:00:00.000Z → 2026-02-18T05:00:00.000Z)
Business address
1315 WEST CENTURY DRIVE
SUITE 150
LOUISVILLE
CO
80027
CO
Mailing address
1315 WEST CENTURY DRIVE
SUITE 150
LOUISVILLE
CO
80027
CO

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

182 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 4 FORM 4 0001628280-26-074569 5062
2026-11-16 424B3 424B3 0001628280-26-074204 333-294802 261561604 33 1348769
2026-11-16 10-Q 10-Q 0001628280-26-074188 001-42646 261560991 34 9145561 1 1
2026-11-16 8-K 8-K 2.02,9.01 0001628280-26-074184 001-42646 261560921 34 477516 1 1
2026-11-04 4 FORM 4 0001628280-26-070304 5072
2026-09-24 8-K 8-K 7.01,9.01 0001628280-26-063328 001-42646 261402326 34 3434603 1 1
2026-08-26 424B3 424B3 0001193125-26-368786 333-294802 261323588 33 68323
2026-08-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000818 13549
2026-08-18 424B3 424B3 0001628280-26-057518 333-294802 261288169 33 1506529
2026-08-18 8-K/A 8-K/A 2.02,9.01 0001628280-26-057510 001-42646 261288141 34 460261 1 1
2026-08-18 10-Q 10-Q 0001628280-26-057508 001-42646 261288130 34 10491210 1 1
2026-08-17 NT 10-Q NT 10-Q 0001193125-26-354303 001-42646 261287669 34 204416
2026-08-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000796 27045
2026-08-12 8-K 8-K 2.02,9.01 0001628280-26-056222 001-42646 261267792 34 471655 1 1
2026-07-15 424B3 424B3 0001193125-26-303734 333-294802 261175739 33 870480
2026-06-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-073031 005-95044 261084356 34 7253
2026-06-09 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001821219-26-000005 005-95044 261077544 34 11421
2026-06-08 424B3 424B3 0001193125-26-260108 333-294802 261070569 33 114030
2026-06-05 4 xslF345X06/form4-06052026_040610.xml 0002108532-26-000008 6399
2026-06-01 4 xslF345X06/form4-06022026_010607.xml 0001116268-26-000011 11620
2026-05-29 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000508 19107
2026-05-29 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000507 23753
2026-05-29 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000504 26328
2026-05-29 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000503 31165
2026-05-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000493 11061
2026-05-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000492 15540
2026-05-28 4 xslF345X06/form4-05282026_100538.xml 0002108524-26-000008 12636
2026-05-27 4 xslF345X06/form4-05282026_120541.xml 0002109180-26-000008 20486
2026-05-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000486 24490
2026-05-26 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001012975-26-000482 005-95044 261021702 34 69033
2026-05-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000481 37521
2026-05-15 424B3 424B3 0001193125-26-227233 333-294802 26989775 33 696093
2026-05-15 10-Q 10-Q 0001193125-26-227206 001-42646 26989692 34 7692433 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001193125-26-224350 001-42646 26980554 34 347124 1 1
2026-05-14 424B3 424B3 0001193125-26-222913 333-294802 26976001 33 36749
2026-05-14 3 xslF345X06/form3-05142026_120509.xml 0001968929-26-000004 9319
2026-05-14 8-K 8-K 5.02 0001193125-26-222903 001-42646 26975984 34 189832 1 1
2026-05-05 4 xslF345X06/form4-05052026_100523.xml 0002108537-26-000008 5488
2026-05-05 4 xslF345X06/form4-05052026_100521.xml 0002109273-26-000008 5479
2026-04-28 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-050373 005-95044 26908136 34 37350
2026-04-24 4 OWNERSHIP DOCUMENT 0001104659-26-048517 30670
2026-04-20 S-8 S-8 0001193125-26-164062 333-295191 26875329 33 335342 1 1
2026-04-15 4/A xslF345X06/form4a-04152026_040401.xml 0001240366-26-000014 6529
2026-04-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000360 10195
2026-04-14 4 xslF345X06/form4-04142026_100419.xml 0001240366-26-000012 5966
2026-04-14 4 xslF345X06/form4-04142026_100401.xml 0002108451-26-000008 5946
2026-04-14 4 xslF345X06/form4-04142026_100418.xml 0001116268-26-000008 6016
2026-04-14 4 xslF345X06/form4-04142026_100431.xml 0001452681-26-000022 5988
2026-04-14 4 xslF345X06/form4-04142026_100428.xml 0001291570-26-000008 5965
2026-04-14 4/A xslF345X06/form4a-04142026_100459.xml 0001452681-26-000020 6106
2026-04-10 424B3 424B3 0001193125-26-151430 333-294802 26855682 33 2415295
2026-04-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001133 333-294802 26853026 33 1878
2026-04-08 8-K 8-K 2.02,9.01 0001193125-26-147667 001-42646 26848320 34 231423 1 1
2026-04-07 CORRESP filename1.htm 0001193125-26-145500 7191
2026-04-07 UPLOAD filename1.pdf 0000000000-26-003481 333-294802 40197
2026-03-31 S-1 S-1 0001193125-26-135000 333-294802 26823640 33 16197145 1 1
2026-03-31 8-K/A 8-K/A 2.02,9.01 0001193125-26-134690 001-42646 26822423 34 1060830 1 1
2026-03-31 8-K/A 8-K/A 4.01,9.01 0001193125-26-134682 001-42646 26822367 34 211108 1 1
2026-03-31 10-K 10-K 0001193125-26-134544 001-42646 26821789 34 6043949 1 1
2026-03-26 8-K 8-K 4.01,9.01 0001193125-26-126442 001-42646 26799014 34 205563 1 1
2026-03-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-100139 005-95044 26739353 34 13333
2026-02-27 3 OWNERSHIP DOCUMENT 0001104659-26-021683 10547
2026-02-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-021657 005-95044 26701221 34 17195
2026-02-25 D xslFormDX01/primary_doc.xml 06b 0001231919-26-000194 021-574650 26679593 33 15932
2026-02-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001821219-26-000002 005-95044 26666043 34 27054
2026-02-18 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001012975-26-000188 005-95044 26651116 34 165465
2026-02-18 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000187 19531
2026-02-18 4 xslF345X05/form4-02182026_010238.xml 0001240366-26-000010 9511
2026-02-18 4 xslF345X05/form4-02182026_010218.xml 0002108451-26-000006 6563
2026-02-18 4 xslF345X05/form4-02182026_010257.xml 0001116268-26-000006 8898
2026-02-18 4 xslF345X05/form4-02182026_010232.xml 0001452681-26-000010 5551
2026-02-18 4 xslF345X05/form4-02182026_010239.xml 0001291570-26-000006 7968
2026-02-18 4 xslF345X05/form4-02182026_010255.xml 0002108524-26-000006 13270
2026-02-18 4 xslF345X05/form4-02182026_010215.xml 0002109273-26-000006 5535
2026-02-18 4 xslF345X05/form4-02182026_010242.xml 0002108537-26-000006 5544
2026-02-18 4 xslF345X05/form4-02182026_010257.xml 0002108532-26-000006 17284
2026-02-18 4 xslF345X05/form4-02182026_010217.xml 0002109180-26-000006 17332
2026-02-18 3 xslF345X02/form3-02182026_010254.xml 0001240366-26-000008 14724
2026-02-18 3 xslF345X02/form3-02182026_010251.xml 0002108451-26-000004 8235
2026-02-18 3 xslF345X02/form3-02182026_010213.xml 0001116268-26-000004 8311
2026-02-18 3 xslF345X02/form3-02182026_010218.xml 0001452681-26-000008 8279
2026-02-18 3 xslF345X02/form3-02182026_010241.xml 0001291570-26-000004 8253
2026-02-18 3 xslF345X02/form3-02182026_010206.xml 0002109273-26-000004 8238
2026-02-18 3 xslF345X02/form3-02182026_010257.xml 0002108524-26-000004 8260
2026-02-18 3 xslF345X02/form3-02182026_010247.xml 0002108537-26-000004 8242
2026-02-18 3 xslF345X02/form3-02182026_010215.xml 0002108532-26-000004 8275
2026-02-18 3 xslF345X02/form3-02182026_010229.xml 0002109180-26-000004 8278
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016528 005-95044 26642889 34 18259
2026-02-17 4 4 0001193125-26-054778 17746
2026-02-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-054801 005-95044 26642120 34 13686
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-26-001998 005-95044 26640623 34 13406
2026-02-17 8-K 8-K 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,8.01,9.01 0001193125-26-053097 001-42646 26636465 34 3635244 1 1
2026-02-13 CERT NYSE CERTIFICATION 0000876661-26-000130 001-42646 26629775 34 404338
2026-02-13 8-A12B 8-A12B 0001193125-26-050171 001-42646 26629683 34 14594
2026-02-13 25 25 0001193125-26-050159 001-42646 26629660 34 13909
2026-02-12 425 425 0001193125-26-048995 001-42646 26627512 34 73068
2026-02-12 8-K 8-K 5.07,7.01,8.01,9.01 0001193125-26-048986 001-42646 26627471 34 266237 1 1
2026-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000312069-26-000051 005-95044 26620656 34 6145
2026-02-09 425 425 0001193125-26-042888 001-42646 26611888 34 22013
2026-02-09 425 425 0001193125-26-041848 001-42646 26609439 34 31560
2026-02-03 425 425 0001193125-26-035824 001-42646 26594246 34 54796
2026-02-03 8-K 8-K 3.01,7.01,9.01 0001193125-26-035805 001-42646 26594156 34 243823 1 1
2026-01-27 425 425 0001193125-26-024383 001-42646 26565345 34 24254
2026-01-26 425 425 0001193125-26-022603 001-42646 26560671 34 26920
2026-01-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000281 333-292582 26558312 33 2597
2026-01-23 424B3 424B3 0001193125-26-021087 333-292582 26556816 33 7405395
2026-01-22 S-4/A S-4/A 0001193125-26-018589 333-292582 26549628 33 30453791 1 1
2026-01-20 S-4/A S-4/A 0001193125-26-015928 333-292582 26541066 33 30806441 1 1
2026-01-08 425 425 0001193125-26-007704 001-42646 26519746 34 68688
2026-01-07 425 425 0001193125-26-005209 001-42646 26513833 34 83003
2026-01-06 425 425 0001193125-26-004475 001-42646 26511720 34 28202
2026-01-05 S-4 S-4 0001193125-26-002732 333-292582 26507691 33 29753527 1 1
2025-12-01 425 425 0001193125-25-303905 001-42646 251539845 34 127335
2025-11-28 425 425 0001193125-25-300920 001-42646 251531835 34 34844
2025-11-19 425 425425 0001193125-25-288122 001-42646 251499536 34 73686
2025-11-14 425 425 0001193125-25-283213 001-42646 251487608 34 33024
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-25-004013 005-95044 251486331 34 10247
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000312069-25-000609 005-95044 251473579 34 6083
2025-11-12 10-Q 10-Q 0001193125-25-277719 001-42646 251473213 34 4899379 1 1
2025-11-05 425 425 0001193125-25-266991 001-42646 251454204 34 27275
2025-11-04 425 425 0001193125-25-264912 001-42646 251450311 34 60154
2025-11-04 8-K 8-K 8.01,9.01 0001193125-25-264893 001-42646 251450258 34 244355 1 1
2025-10-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-104451 005-95044 251436757 34 27499
2025-10-30 DRS filename1.htm 0001193125-25-257008 377-08628 251431747 33 6320868
2025-10-15 425 425 0001193125-25-240274 001-42646 251394992 34 29588
2025-10-08 425 425 0001193125-25-234526 001-42646 251382461 34 59740
2025-10-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-097614 005-95044 251380944 34 6954
2025-10-06 425 425 0001193125-25-231996 001-42646 251377307 34 234686
2025-09-24 425 425 0001193125-25-215465 001-42646 251338772 34 62017
2025-09-11 425 425 0001193125-25-201333 001-42646 251308684 34 25807
2025-09-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-114101 005-95044 251307447 34 28426
2025-09-09 425 425 0001193125-25-199206 001-42646 251303610 34 24728
2025-09-09 425 425 0001193125-25-198474 001-42646 251301047 34 21455
2025-09-08 425 425 0001193125-25-198382 001-42646 251300285 34 76881
2025-09-08 425 425 0001193125-25-198375 001-42646 251300242 34 30878
2025-09-08 425 425 0001193125-25-198372 001-42646 251300233 34 55626
2025-09-08 425 425 0001193125-25-198363 001-42646 251300208 34 19332
2025-09-08 425 425 0001193125-25-198362 001-42646 251300207 34 22929
2025-09-08 425 425 0001193125-25-198355 001-42646 251300199 34 19027
2025-09-08 425 425 0001193125-25-197780 001-42646 251298656 34 32838654
2025-09-08 8-K 8-K 1.01,7.01,9.01 0001193125-25-197773 001-42646 251298650 34 33468894 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-108827 005-95044 251218411 34 17343
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-012213 005-95044 251218337 34 13770
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-25-002926 005-95044 251218177 34 16618
2025-08-13 10-Q 10-Q 0001193125-25-179808 001-42646 251211515 34 4568700 1 1
2025-08-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000312069-25-000546 005-95044 251208308 34 6049
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001062993-25-014209 005-95044 251208041 34 7520
2025-08-11 3 3 0000950170-25-106615 2849
2025-08-11 3 3 0000950170-25-106579 2816
2025-08-04 8-K 8-K 5.02,9.01 0001193125-25-172598 001-42646 251180234 34 227601 1 1
2025-07-02 8-K 8-K 8.01,9.01 0001193125-25-155005 001-42646 251102285 34 204361 1 1
2025-06-27 4 4 0000950170-25-090878 5938
2025-06-27 3 3 0000950170-25-090866 5732
2025-06-13 10-Q 10-Q 0001193125-25-140724 001-42646 251046486 34 2835918 1 1
2025-05-21 8-K 8-K 8.01,9.01 0001193125-25-123979 001-42646 25973216 34 319441 1 1
2025-05-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-075748 005-95044 25973016 34 17405
2025-05-21 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-075642 005-95044 25972464 34 154579
2025-05-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001062993-25-009846 005-95044 25967646 34 11905
2025-05-19 4 4 0000950170-25-074309 8128
2025-05-16 8-K 8-K 1.01,3.02,5.02,5.03,8.01,9.01 0001193125-25-121305 001-42646 25956980 34 1616706 1 1
2025-05-15 424B4 424B4 0001193125-25-119969 333-286799 25947574 33 1840052
2025-05-14 3 3 0000950170-25-070889 7226
2025-05-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001565 333-286799 25942457 33 1735
2025-05-13 3 3 0000950170-25-070830 2897
2025-05-13 3 3 0000950170-25-070825 2877
2025-05-13 S-1MEF S-1MEF 0001193125-25-119074 333-287245 25942275 33 146563
2025-05-13 CERT 8A_Cert_CCCX.pdf 0001354457-25-000412 001-42646 25938819 34 124419
2025-05-13 8-A12B 8-A12B 0001193125-25-118382 001-42646 25937437 34 14704
2025-05-12 CORRESP filename1.htm 0001193125-25-117657 7121
2025-05-12 CORRESP filename1.htm 0001193125-25-117651 5756
2025-05-09 S-1/A S-1/A 0001193125-25-116188 333-286799 25928091 33 1894534
2025-04-28 S-1 S-1 0001193125-25-100727 333-286799 25881225 33 3354549
2025-04-07 DRS/A filename1.htm 0000950123-25-003342 377-07129 25816090 33 2094181
2025-04-04 DRSLTR filename1.htm 0000950123-25-003343 12496
2025-03-27 UPLOAD filename1.pdf 0000000000-25-003283 377-07129 45405
2025-03-06 DRSLTR filename1.htm 0000950123-25-003011 7173
2025-03-06 DRS/A filename1.htm 0000950123-25-003010 377-07129 25716413 33 2048913
2024-06-20 UPLOAD filename1.pdf 0000000000-24-007052 377-07129 43485
2024-06-10 DRSLTR filename1.htm 0000950123-24-006174 14059
2024-06-10 DRS/A filename1.htm 0000950123-24-006173 377-07129 241033789 33 1652588
2024-04-04 UPLOAD filename1.pdf 0000000000-24-003636 377-07129 47961
2024-03-08 DRS filename1.htm 0000950123-24-002818 377-07129 24734530 33 1905568

Latest XBRL company facts

One latest value per concept from companyfacts (191 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 226.25M 2026-11-12 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
dei EntityPublicFloat Entity Public Float USD 426.45M 2025-06-30 2025 FY 10-K 2026-03-31 0001193125-26-134544
ffd NetFeeAmt NetFeeAmt USD 60,607.57 2026-04-20 S-8 2026-04-20 0001193125-26-164062
ffd TtlFeeAmt TtlFeeAmt USD 60,607.57 2026-04-20 S-8 2026-04-20 0001193125-26-164062
ffd TtlOfferingAmt TtlOfferingAmt USD 438.87M 2026-04-20 S-8 2026-04-20 0001193125-26-164062
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-20 S-8 2026-04-20 0001193125-26-164062
us-gaap AcceleratedShareRepurchaseProgramAdjustment Accelerated Share Repurchase Program, Adjustment USD 17.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.14M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 8.42M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 45.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 13.55M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.51M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 874.52M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 667,472 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 31.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 31.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -3.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 37.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap Assets Assets USD 640.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AssetsCurrent Assets, Current USD 506.98M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 534.96M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 423.69M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.96M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 510.09M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 27,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 769,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 82.79M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 81.31M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 427.30M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 426.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 508.13M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 426.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 81.31M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 3.32M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 41.40M 2025-05-15 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap Cash Cash USD 702,154 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 51.89M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 53.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 41.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 300,000 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 10.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.40B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 226.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 226.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CommonStockValue Common Stock, Value, Issued USD 23,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -76.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ContractWithCustomerAssetGrossCurrent Contract with Customer, Asset, before Allowance for Credit Loss, Current USD 80,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination Contract with Customer, Asset, Increase (Decrease) for Contract Acquired in Business Combination USD 362,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ContractWithCustomerAssetReclassifiedToReceivable Contract with Customer, Asset, Reclassified to Receivable USD 483,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 7.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -11.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ContractWithCustomerReceivableAfterAllowanceForCreditLoss Contract with Customer, Receivable, after Allowance for Credit Loss USD 8.40M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 133.24M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap CostOfRevenue Cost of Revenue USD 29.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 0 2025-12-31 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 52.30M 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 61.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 3.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 75.63M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 34.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 12.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap Goodwill Goodwill USD 9.31M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap GrantsReceivable Grants Receivable USD 108,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap GrossProfit Gross Profit USD 3.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -74.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -475,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 35.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 641,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 3.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -460,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 165,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 2.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 404,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap InventoryNet Inventory, Net USD 7.79M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 4.48M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 4,827 2024-01-04 2024-03-31 2025 Q1 10-Q 2025-06-13 0001193125-25-140724
us-gaap LeaseCost Lease, Cost USD 2.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 12.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap Liabilities Liabilities USD 74.97M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 640.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap LiabilitiesCurrent Liabilities, Current USD 58.56M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 3.32M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ManagingMemberOrGeneralPartnerSubsequentDistributionAmount Managing Member or General Partner, Subsequent Distribution Amount USD 30,000 2025-05-14 2025 Q1 10-Q 2025-06-13 0001193125-25-140724
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 529.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -465.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -22.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -74.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap NoninterestExpenseDirectorsFees Noninterest Expense Directors Fees USD 93,750 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -97.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 16.91M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 501,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 16.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 15.57M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.084 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherAssetsCurrent Other Assets, Current USD 331,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 14.44M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -323,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -2.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -176,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 13.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 23.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherNonrecurringIncome Other Nonrecurring Income USD 1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 46,000 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PaymentForAdministrativeFees Payment for Administrative Fees USD 225,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap PaymentsForRoyalties Payments for Royalties USD 25,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 28.30M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 620.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 414.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 1 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 7.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PrepaidInsurance Prepaid Insurance USD 1.05M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 164.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ProceedsFromSaleOfTrustAssetsToPayExpenses Proceeds from Sale of Trust Assets to Pay Expenses USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 771,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 21.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 12.79M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ProvisionForLossOnContracts Provision for Loss on Contracts USD 100,000 2026-06-30 2026 Q2 10-Q 2026-08-18 0001628280-26-057508
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 34.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap RestrictedCash Restricted Cash USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -307.59M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 32.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap Revenues Revenues USD 9.46M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 414.00M 2025-05-15 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 10 2025-05-15 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 68.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 31.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 239,765 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0.89 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 179,825 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0.89 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227206
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 33.42M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 216.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 17.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 1.18 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 139.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 701,419 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 8.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 261.71M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 25.80M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.34 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 13.16 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 565.44M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 1,825 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 10.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 25,000 2024-01-04 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax Translation Adjustment Functional to Reporting Currency, Gain (Loss), Reclassified to Earnings, Net of Tax USD -411,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 4.34M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134544
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 10.41M 2026-06-30 2026 Q2 10-Q 2026-08-18 0001628280-26-057508
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 188.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 1.35M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-06-13 0001193125-25-140724
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 188.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001628280-26-074188

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →